Gene+

About:

Gene+ is a biotechnology company offering genetic research, gene panel development, mutation detection, and tumor gene detection services.

Website: https://en.geneplus.cn/

Top Investors: Huagai Capital

Description:

Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.

Total Funding Amount:

250M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2015-01-01

Contact Email:

global.service(AT)geneplus.org.cn

Founders:

Ling Yang, Xin Yi

Number of Employees:

1001-5000

Last Funding Date:

2020-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai